Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Pfizer Inc. Upgrade
Xencor, Inc. Upgrade
Glaukos Corp. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade